5-Chloro-1-methylquinazoline-2,4(1H,3H)-dione

Catalog No.: 
ACSGXW897
CAS No.: 
49845-82-1
Molecular Formula: 
C9H7ClN2O2
Molecular Weight: 
210.62
5-Chloro-1-methylquinazoline-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$167.00In stockIn stock
25g95%$579.00In stockIn stock
100g95%$2108.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-1-methylquinazoline-2,4(1H,3H)-dione
IUPAC Name5-chloro-1-methylquinazoline-2,4(1H,3H)-dione
Molecular FormulaC9H7ClN2O2
Molecular Weight210.62
SMILESO=C1N(C2C=CC=C(Cl)C=2C(=O)N1)C
InChI KeyQRDPCBDIDPJSRF-UHFFFAOYSA-N
Synonym2,4(1H,3H)-Quinazolinedione, 5-chloro-1-methyl-;5-Chloro-1-methylquinazoline-2,4(1H,3H)-dione
CAS No.49845-82-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSGXW897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACRQZJ506 route compound structure diagram
    ACRQZJ50678754-81-1In Stock
  4. Then
  5. ACSGXW897 route product structure diagram
    ACSGXW89749845-82-1In Stock
Inquiry

2. ACSGXW897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSGXW897 route product structure diagram
    ACSGXW89749845-82-1In Stock
Inquiry

3. ACSGXW897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSGXW897 route product structure diagram
    ACSGXW89749845-82-1In Stock
Inquiry

Comments (0)